paclitaxel has been researched along with Neointima in 117 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 103 (88.03) | 24.3611 |
| 2020's | 14 (11.97) | 2.80 |
| Authors | Studies |
|---|---|
| Bettink, S; Bienek, S; Gemeinhardt, O; Kusmierczuk, M; Scheller, B; Schnorr, B | 1 |
| Aihara, K; Ikari, Y; Kato, T; Nakamura, N; Nakazawa, G; Nakazawa, K; Noda, S; Torii, S | 1 |
| Ates, I; Avci, R; Cilingiroglu, M; Dijkstra, J; Feldman, MD; Hoyt, T; Iliescu, C; Kose, G; Lendel, V; Marmagkiolis, K; McElroy, A; McIntosh, V; Mego, D; Milner, TE; Okutucu, S; Paixao, A; Park, J; Shaar, M | 1 |
| Banerjee, S; Fehder, D; Fry, ETA; Ginor, R; Kothapalli, P; Monteleone, PP; Pirwitz, MJ; Stern, AD; Vollmar, D | 1 |
| Bettink, S; Bienek, S; Kusmierczuk, M; Mittag, A; Scheller, B | 1 |
| Ang, HY; Chaw, SY; Chong, TT; Huang, Y; Ng, JCK; Phua, JL; Venkatraman, S; Wong, PEH; Xiong, GM | 1 |
| Byrne, M; Byron, K; Chen, YC; Dear, AE; Gaspari, TA; Kaye, DM; Liu, H; Ozcelik, B; Perlmutter, P; Sama, GR; Subbiah, J; Walker, A; Widdop, RE | 1 |
| Ando, K; Fujihara, M; Iida, O; Kawasaki, D; Kuramitsu, S; Soga, Y; Tomoi, Y | 1 |
| Ito, N; Kadoya, Y; Kuwabara, K; Matoba, S; Wakana, N; Yanishi, K; Yashige, M; Zen, K | 1 |
| Akahori, H; Imanaka, T; Ishihara, M; Kimura, T; Miki, K; Tanaka, T; Yanaka, K; Yoshihara, N | 1 |
| Asai, M; Hata, Y; Iida, O; Ishihara, T; Kanda, T; Kurata, N; Mano, T; Masuda, M; Matsuda, Y; Nanto, K; Okamoto, S; Tsujimura, T | 1 |
| Cornelissen, A; Fernandez, R; Finn, AV; Fuller, D; Gadhoke, N; Guo, L; Jinnouchi, H; Kawai, K; Kawakami, R; Kolodgie, FD; Kuntz, S; Mori, M; Paek, KH; Ragheb, A; Sakamoto, A; Sato, Y; Torii, S; Virmani, R; Young, B | 1 |
| Byrne, M; Dear, AE; E Thompson, P; Forsythe, J; Kaye, DM; Liu, H; Mornane, PJ; Mountford, S; Pasic, P; Robinson, A; Rodda, A; Sama, GR; Thissen, H | 1 |
| Ando, K; Hiramori, S; Kuramitsu, S; Shinozaki, T; Soga, Y; Tomoi, Y | 1 |
| Maranhão, RC; Noronha, IL; Pepineli, R; Santana, AC; Silva, FMO; Stolf, NAG; Tavoni, TM | 1 |
| Fitzgerald, PJ; Honda, Y; Huang, CC; Kawarada, O; Kitahara, H; Matsuyama, Y; Muramatsu, T; Nakamura, M; Nakatani, D; Nanto, S; Sakamoto, K; Sakata, K; Waseda, K; Yamada, R; Yock, PG; Yokoi, H | 1 |
| Cheng, Y; Conditt, GB; Gasior, P; Granada, JF; Kaluza, GL; McGregor, J; Valencia, AF | 1 |
| AbdelWahab, A; Boshra, H; El-Mokadem, M; El-Ramly, M; Hassan, A | 1 |
| Ashikaga, T; Fukushima, T; Hatano, Y; Isobe, M; Ueshima, D; Yamamoto, T; Yasuhiro, M; Yoshikawa, S | 1 |
| Finn, AV; Harari, E; Kolodgie, FD; Mori, H; Ragheb, A; Romero, ME; Torii, S; Virmani, R; Yahagi, K; Young, B | 1 |
| Adachi, H; Ihara, M; Kurimoto, T; Nanto, S; Nojima, Y | 1 |
| Bettink, S; Clever, YP; Häckel, A; Kamann, S; Löchel, M; Peters, D; Schellenberger, E; Scheller, B; Speck, U; Trog, S | 1 |
| Brugaletta, S; Filipiak, KJ; Jąkała, J; Kochman, J; Kołtowski, Ł; Malinowski, K; Mazurek, T; Opolski, G; Pietrasik, A; Proniewska, K; Rdzanek, A; Tomaniak, M | 1 |
| Abizaid, A; Meneguz-Moreno, RA; Ribamar Costa, J | 1 |
| Fujii, K; Fukunaga, M; Hirata, KI; Horimatsu, T; Iida, O; Ishihara, T; Kozuki, A; Nanto, S; Otake, H; Shinke, T; Shite, J; Takahara, M; Terashita, D; Tsukiyama, Y; Uematsu, M; Zen, K | 1 |
| Akasaka, T; Hirata, K; Imanishi, T; Ino, Y; Ishibashi, K; Kashiwagi, M; Kitabata, H; Komukai, K; Kubo, T; Mizukoshi, M; Takarada, S; Takemoto, K; Tanaka, A; Tanimoto, T | 1 |
| E, Y; Fan, H; He, N | 1 |
| Hou, J; Jang, IK; Jia, H; Kong, J; Liu, H; Ma, L; Xing, L; Yu, B; Zhang, S | 1 |
| de Boer, SW; de Vries, JP; Elgersma, O; Fioole, B; Heyligers, JM; Karimi, A; Lohle, PN; Nolthenius, RP; van den Heuvel, DA; Vos, JA; Vroegindeweij, D | 1 |
| Chevalier, B; Coe, J; Cutlip, DE; Dimario, C; Grube, E; Neumann, FJ; Ormiston, J; Schwartz, LB; Whitbourn, R; Williams, DO | 1 |
| Adden, N; Braune, M; Riedmüller, J; Savard, C; Waksman, R; Wittchow, E | 1 |
| Buszman, PE; Buszman, PP; Gasior, P; Granada, JF; Jelonek, M; Milewski, K; Pajak, J; Peppas, A; Tellez, A; Zurakowski, A | 1 |
| Filipiak, KJ; Kochman, J; Opolski, G; Pawlak, M; Pietrasik, A; Rdzanek, A; Ścibisz, A | 1 |
| Ito, T; Matsuda, O; Murase, S; Murata, A; Suzuki, Y; Yamaguchi, T | 1 |
| Afari, M; Buszman, PP; Cheng, Y; Conditt, GB; Granada, JF; Kaluza, GL; McGregor, JC; Milewski, K; Stenoien, M; Tellez, A | 1 |
| Afari, ME; Buszman, PP; Conditt, GB; Granada, JF; Kaluza, GL; McGregor, JC; Peppas, A; Rousselle, SD; Stenoien, M; Tellez, A | 1 |
| Bedogni, F; Berti, S; Biondi-Zoccai, G; Colombo, A; Cortese, B; Cremonesi, A; Limbruno, U; Sgueglia, GA | 1 |
| Finn, AV; Foerst, J; Kolodgie, FD; Kutys, R; Ladich, E; Nakano, M; Newell, JB; Otsuka, F; Sakakura, K; Virmani, R; Vorpahl, M | 1 |
| Calderas, C; Condado, JA; Condado, JF; Fitzgerald, P; Flores, A; Honda, Y; Mueller, A; Nakatani, D; Thomas, J; Waseda, K | 1 |
| Borghesi, M; Campo, G; Cangiano, E; Cavazza, C; Marchesini, J; Minarelli, M; Parrinello, G; Scalone, A; Tebaldi, M; Tumscitz, C; Valgimigli, M; Vranckx, P | 1 |
| Akhmedov, A; Beer, JH; Camici, GG; Eickner, T; Holy, EW; Jakob, P; Lüscher, TF; Schmitz, KP; Sternberg, K; Tanner, FC | 1 |
| Buszman, PE; Buszman, PP; Granada, JF; Gwiazdowska-Nowotka, B; Jelonek, M; Krauze, A; Milewski, K; Orlik, B; Pająk, J; Tellez, A; Wojakowski, W | 1 |
| Egami, Y; Makino, N; Mori, N; Nakamura, D; Nishino, M; Shutta, R; Tanaka, A; Taniike, M; Tanouchi, J; Yoshimura, T | 1 |
| Jenei, C; Köszegi, Z; Marty, F; Szük, T; Vajda, G | 1 |
| Baek, I; Hwang, J; Kim, DJ; Kim, H; Park, J; Park, JS | 1 |
| Egami, Y; Hamasaki, T; Hara, M; Kato, H; Lee, Y; Makino, N; Nakamura, D; Nishino, M; Sakata, Y; Shutta, R; Taniike, M; Tanouchi, J; Yamada, Y; Yoshimura, T | 1 |
| Alvarez-Contreras, L; Brugaletta, S; Cola, C; del Blanco, BG; Díaz, J; García-Picart, J; Martí, V; Martín-Yuste, V; Pinar, E; Ruiz-Salmeron, R; Sabaté, M; Shiratori, Y | 1 |
| Camuglia, AC; Lavi, S | 1 |
| Hariki, H; Hiranuma, N; Hirata, K; Inoue, T; Iwasaki, M; Kinutani, H; Konishi, A; Kozuki, A; Kuroda, M; Nakagawa, M; Nishio, R; Osue, T; Otake, H; Shinke, T; Shite, J; Takaya, T; Taniguchi, Y | 1 |
| Allocco, D; Dawkins, KD; Ellis, SG; Guagliumi, G; Jiang, S; Kobayashi, N; Maehara, A; McAndrew, TC; Mintz, GS; Ormiston, JA; Stone, GW; Turco, MA; Weissman, NJ; Witzenbichler, B | 1 |
| Akashi, YJ; Harada, T; Kamijima, R; Kongoji, K; Koyama, K; Kuwata, S; Mitarai, T; Nakano, E; Tanabe, Y; Yamazaki, H; Yoneyama, K | 1 |
| Akashi, YJ; Kamijima, R; Kawaguchi, H; Kongoji, K; Koyama, K; Kuwata, S; Mitarai, T; Takakura, N; Tanabe, Y; Yamazaki, H; Yoneyama, K | 1 |
| Fujii, K; Hao, H; Hirayama, A; Hirota, S; Imanaka, T; Ishibashi-Ueda, H; Kawakami, R; Kawano, T; Masuyama, T; Takayama, T | 1 |
| Dawkins, KD; Ellis, SG; Grube, E; Kruk, M; Mandinov, L; Mintz, GS; Opolski, MP; Popma, JJ; Pracon, R; Pregowski, J; Stone, GW; Wang, H; Weissman, NJ | 1 |
| Abrignani, S; Altobelli, S; D'Onofrio, A; Da Ros, V; Del Giudice, C; Gandini, R; Sallustio, F; Simonetti, G; Stanzione, P; Vasili, E | 1 |
| Böhm, M; Clever, YP; Cremers, B; Dietz, U; Hauschild, T; Kleber, FX; Scheller, B; Schulz, A; Waliszewski, M | 1 |
| Figulla, HR; Gassdorf, J; Goebel, B; Janiak, F; Jung, C; Nitsche, K; Otto, S; Poerner, TC; Scheller, B | 1 |
| Figulla, HR; Gassdorf, J; Goebel, B; Janiak, F; Jung, C; Nitsche, K; Otto, S; Poerner, TC | 1 |
| Guy, LG; Joner, M; Leclerc, G; Sanchez, OD; Virmani, R; Zarpak, R | 1 |
| Deng, Y; Dong, Q; Kong, J; Liu, W; Lu, Y | 1 |
| Jing, L; Lü, J; Luo, X; Ning, Q; Tian, D; Wang, D; Wang, W; Xie, M; Zhang, S | 1 |
| Aihara, H; Ando, K; Kuramitsu, S; Nobuyoshi, M; Soga, Y; Tomoi, Y | 1 |
| Abe, S; Inoue, T; Kageyama, M; Komatsu, T; Nasuno, T; Sakuma, M; Taguchi, I; Tokura, M; Toyoda, S | 1 |
| Baumgartner, S; Jüni, P; Meier, B; Räber, L; Stefanini, GG; Taniwaki, M; Wenaweser, P; Windecker, S; Zanchin, T; Zaugg, S | 1 |
| Cheng, Y; Conditt, GB; Gongora, CA; Granada, JF; Kaluza, GL; McGregor, J; Shibuya, M; Tellez, A; Wessler, JD | 1 |
| Bantleon, R; Domschke, N; Grözinger, G; Schmehl, J; Spira, D; Wiesinger, B; Wiskirchen, J | 1 |
| Fujii, K; Fukunaga, M; Horimatsu, T; Imanaka, T; Ishihara, M; Masuyama, T; Miki, K; Naito, Y; Nishimura, M; Saita, T; Shibuya, M; Sumiyoshi, A; Tamaru, H | 1 |
| Collins, MB; Dohi, T; Goto, K; Kirtane, AJ; Kobayashi, N; Kodali, SK; Leon, MB; Maehara, A; Matsumura, M; Mintz, GS; Moses, JW; Parikh, MA; Rabbani, LE; Zhao, Z | 1 |
| Fujiwara, R; Fukuyama, Y; Hirata, K; Imamura, K; Kawashima, S; Kijima, Y; Kozuki, A; Masano, T; Nagoshi, R; Nakano, S; Otake, H; Shibata, H; Shinke, T; Shite, J; Takeshige, R; Tsukiyama, Y; Yanaka, K | 1 |
| Barry, C; Dillon, KN; Garza, JA; Granada, JF; Li, Y; Rousselle, SD; Tellez, A | 1 |
| Abizaid, A; Costa, RA; Grube, E; Hauptmann, KE; Magalhães, MA; Mehran, R; Parise, H; Schofer, J; Schuler, GC | 1 |
| Bil, J; Costa, RA; Gil, KE; Gil, RJ; Vassiliev, D | 1 |
| Lee, MS; Sethi, SS | 1 |
| Bergler-Klein, J; Gray, WA; Gyöngyösi, M; Jambrik, Z; Lukovic, D; Maurer, G; Pavo, IJ; Pavo, N; Plass, CA; Sabdyusheva, I; Samaha, E; Stahnke, S; von Strandmann, RP; Zlabinger, K | 1 |
| Huang, C; Mei, H; Zheng, X; Zhou, M | 1 |
| Dawkins, KD; Eppihimer, M; Heil, J; Hitzman, C; Hou, D; Huibregtse, BA; Kocur, G; Stejskal, E; Stoffregen, W | 1 |
| Chibana, H; Fukumoto, Y; Ishimatsu, T; Itaya, N; Kimura, T; Mitsutake, Y; Nakayoshi, T; Ohtsuka, M; Sasaki, KI; Sasaki, M; Ueno, T; Yokoyama, S | 1 |
| Kolodgie, FD; Ladich, E; Mori, H; Pacheco, E; Virmani, R; Yahagi, K | 1 |
| Cheng, Y; Conditt, GB; Doshi, M; Granada, JF; Gray, W; Kaluza, GL; McGregor, J; Shibuya, M; Sojitra, P; Yi, GH | 1 |
| Bienek, S; Binyamin, G; Clever, YP; Cremers, B; Kelsch, B; Konstantino, E; Scheller, B; Seifert, P; Speck, U | 1 |
| Fitzgerald, PJ; Fujii, K; Fukunaga, M; Honda, Y; Horimatsu, T; Imanaka, T; Ishihara, M; Masuyama, T; Miki, K; Nishimura, M; Shibuya, M; Tamaru, H | 1 |
| Mizuno, K; Murakami, D; Okamatsu, K; Seino, Y; Takano, M; Yamamoto, M | 1 |
| Alexopoulos, D; Damelou, A; Davlouros, PA; Karantalis, V; Mavronasiou, E; Nikokiris, G; Tsigkas, G; Xanthopoulou, I | 1 |
| Abelson, M; Brown, B; Conway, D; Hellig, F; Hirata, K; Khan, S; Kozuki, A; Miyoshi, N; Mpe, M; Ntsekhe, M; Sawada, T; Shinke, T; Shite, J | 1 |
| Ako, J; Fitzgerald, PJ; Hirata, K; Honda, Y; Ikeno, F; Miyoshi, N; Otake, H; Shinke, T; Shite, J; Teramoto, T | 1 |
| Bezerra, HG; Costa, MA; Cristea, E; Dressler, O; Guagliumi, G; Lansky, AJ; Lortkipanidze, N; Maehara, A; Matiashvili, A; Mehran, R; Mihalcsik, L; Mintz, GS; Musumeci, G; Parise, H; Sirbu, V; Stone, GW; Suzuki, N; Trivisonno, A; Valsecchi, O | 1 |
| Bayer, G; Byrne, RA; Joner, M; Lapointe, JM; Radke, PW; Steigerwald, K; Wittchow, E | 1 |
| Abizaid, A; Ako, J; Cohen, SA; Courtney, BK; Fitzgerald, PJ; Honda, Y; Macours, N; Ormiston, JA; Otake, H; Popma, JJ; Rogers, C; Shimohama, T; Spaulding, C; Waseda, K | 1 |
| Egami, Y; Hara, M; Kato, H; Makino, N; Nishino, M; Shutta, R; Taniike, M; Tanouchi, J; Yamada, Y | 1 |
| Ahn, Y; Cho, MC; Jeong, MH; Kim, DW; Kwon, JS; Park, RK; Shim, TJ | 1 |
| Fujii, K; Gabbiani, G; Hao, H; Hirota, S; Ishibashi-Ueda, H; Shite, J; Tsujimoto, M; Ueda, Y | 1 |
| Cho, JM; Choi, D; Choi, SY; Hong, MK; Jang, Y; Kim, BK; Kim, DM; Kim, JS; Ko, YG; Yoon, JH | 1 |
| Asai, M; Higo, T; Hirata, A; Kashiwase, K; Kodama, K; Matsuo, K; Murakami, A; Nemoto, T; Nishio, M; Ueda, Y | 1 |
| Aboodi, MS; Conditt, GB; Granada, JF; Gray, WA; Kaluza, GL; McGregor, JC; Milewski, K; Stenoien, M; Tellez, A; Thim, T; Virmani, R; Yi, GH | 1 |
| Hamamdzic, D; Huibregtse, BA; Keane, MG; Llano, R; Patel, DB; Seifert, PS; Wang, H; Wilensky, RL; Wilson, GJ; Winsor-Hines, D | 1 |
| Baek, I; Bai, CZ; Hwang, J; Kim, DJ; Park, J; Park, JS | 1 |
| Bronson, RT; Chan, JM; Drum, CL; Farokhzad, OC; Golomb, G; Langer, R; Rhee, JW | 1 |
| Abdel-Karim, AR; Addo, T; Banerjee, S; Berger, P; Bissett, JK; Brilakis, ES; DaSilva, M; de Lemos, JA; Fasseas, P; Haagen, D; Jeroudi, OM; Kar, B; Karyofillis, P; Lichtenwalter, C; Michael, TT; Obel, O; Raghunathan, D; Rangan, BV; Roesle, M; Rossen, J; Sachdeva, R; Saeed, B; Voudris, VV | 1 |
| Clever, YP; Cremers, B; Hattangadi, N; Kelsch, B; Mahnkopf, D; Scheller, B; Speck, U; Taupitz, M | 1 |
| Byrne, RA; Hartwig, S; Joner, M; Leclerc, G; Radke, PW; Steigerwald, K; Wittchow, E | 1 |
| Airaksinen, KE; Karjalainen, PP; Lehtinen, T; Ylitalo, A | 1 |
| Ahn, JM; Cho, SW; Hwang, KW; Kang, SJ; Kim, WJ; Kim, YG; Kim, YH; Kim, YR; Lee, CW; Lee, JY; Lee, SW; Park, DW; Park, GM; Park, SJ; Park, SW; Song, HG; Sun, BJ | 1 |
| Aboodi, MS; Biedermann, M; Clever, YP; Cremers, B; Granada, JF; Kaluza, GL; Kelsch, B; Milewski, K; Scheller, B; Thim, T | 1 |
| Brancati, MF; Burzotta, F; Coluccia, V; Crea, F; De Maria, G; Leone, AM; Niccoli, G; Porto, I; Schiavoni, G; Tommasino, A; Trani, C | 1 |
| Biedermann, M; Böhm, M; Clever, YP; Cremers, B; Hanisch, U; Kelsch, B; Mahnkopf, D; Schaffner, S; Scheller, B; Speck, U | 1 |
| Hariki, H; Hiranuma, N; Hirata, K; Inoue, T; Kawamori, H; Kinutani, H; Kozuki, A; Miyoshi, N; Nagoshi, R; Nakagawa, M; Nishio, R; Osue, T; Otake, H; Shinke, T; Shite, J; Taniguchi, Y | 1 |
| Bouchard, A; Guy, LG; Hsu, S; Lema, P; Polyakov, I; Savard, C; Sheehy, A; Tai, J | 1 |
| Böhm, M; Clever, Y; Cremers, B; Fischer, D; Klein, G; Schäfer, A; Scheller, B | 1 |
| Baumgartner, S; Buellesfeld, L; Garcia, HM; Garcia-Garcia, HM; Jüni, P; Justiz, J; Kalesan, B; Khattab, AA; Meier, B; Moschovitis, A; Pilgrim, T; Räber, L; Serruys, PW; Wenaweser, P; Windecker, S | 1 |
| Ali, Z; Alp, NJ; Channon, KM; Crabtree, MJ; Douglas, G; Hale, AB; Hoerr, RA; McNeill, E; Patel, J; Van Kampen, E | 1 |
| Egami, Y; Kato, H; Lee, Y; Makino, N; Nakamura, D; Nishino, M; Shutta, R; Taniike, M; Tanouchi, J; Yamada, Y; Yoshimura, T | 1 |
| Alfonso, F; Medina, M; Sandoval, J | 1 |
| Ako, J; Fitzgerald, PJ; Hasegawa, T; Honda, Y; Lima-Filho, MO; Sakurai, R; Shimohama, T; Stone, GW; Sudhir, K; Tsujino, I; Waseda, K; Yamasaki, M | 1 |
| Choi, D; Hong, MK; Jang, Y; Kim, BK; Kim, JS; Ko, YG; Lee, SY; Shin, DH | 1 |
| Fitzgerald, PJ; Honda, Y; Kume, T; Nakatani, D; Otake, H; Sakata, K; Waseda, K; Yock, PG | 1 |
| Choi, D; Hong, MK; Jang, Y; Kim, BK; Kim, JS; Ko, YG; Shin, DH | 1 |
| Hariki, H; Hayashi, T; Hiranuma, N; Hirata, K; Inoue, T; Iwasaki, M; Kadotani, M; Kato, H; Kawamori, H; Kinutani, H; Konishi, A; Kozuki, A; Matsumoto, D; Miyoshi, N; Nagoshi, R; Nakagawa, M; Nishio, R; Ohnishi, Y; Ohsue, T; Otake, H; Shinke, T; Shite, J; Takaya, T; Taniguchi, Y; Yamada, S; Yasaka, Y; Yokoyama, M | 1 |
5 review(s) available for paclitaxel and Neointima
| Article | Year |
|---|---|
Drug-Coated Balloons: Hope or Hot Air: Update on the Role of Coronary DCB.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Equipment Failure; Foreign-Body Migration; Humans; Neointima; Paclitaxel; Prosthesis Design; Sirolimus; Stents; Treatment Outcome | 2018 |
A novel "pro-healing" approach: the COMBO™ dual therapy stent from a pathological view.
Topics: Antibodies, Monoclonal; Antigens, CD34; Drug-Eluting Stents; Endothelial Progenitor Cells; Humans; Neointima; Paclitaxel; Polymers; Prosthesis Design; Sirolimus; Thrombosis | 2015 |
Drug-Coated Balloons for Infrainguinal Peripheral Artery Disease.
Topics: Angioplasty; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Constriction, Pathologic; Drug-Eluting Stents; Femoral Artery; Humans; Hyperplasia; Long Term Adverse Effects; Neointima; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Vascular Patency | 2016 |
Drug-eluting stent: importance of clinico-pathological correlations.
Topics: Coronary Vessels; Drug-Eluting Stents; Humans; Hyperplasia; Inflammation; Neointima; Paclitaxel; Risk Factors; Sirolimus; Thrombosis | 2011 |
Impact of diabetes mellitus on vessel response in the drug-eluting stent era: pooled volumetric intravascular ultrasound analyses.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Diabetes Mellitus; Drug-Eluting Stents; Everolimus; Female; Humans; Hyperplasia; Linear Models; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Neointima; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2012 |
29 trial(s) available for paclitaxel and Neointima
| Article | Year |
|---|---|
Vascular Response After FP-PES Versus Polymer-Free Paclitaxel-Eluting Stent Implantation in Femoropopliteal Artery Lesions: A Serial Intravascular Ultrasound Study.
Topics: Cardiovascular Agents; Coronary Stenosis; Drug-Eluting Stents; Endovascular Procedures; Femoral Artery; Humans; Japan; Neointima; Paclitaxel; Peripheral Arterial Disease; Polymers; Popliteal Artery; Predictive Value of Tests; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Vascular Patency | 2020 |
Temporal Course of Vascular Response After Fluoropolymer Paclitaxel-Eluting Stent Implantation for Femoropopliteal Artery Lesions.
Topics: Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Femoral Artery; Humans; Neointima; Paclitaxel; Tomography, Optical Coherence; Treatment Outcome | 2021 |
Impact of attenuated-signal plaque observed by intravascular ultrasound on vessel response after drug-eluting stent implantation.
Topics: Aged; Cardiovascular Agents; Cell Proliferation; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Japan; Male; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Vascular Calcification | 2017 |
Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
Topics: Adolescent; Adult; Aged; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Egypt; Female; Humans; Male; Metals; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Risk Factors; Stents; Time Factors; Treatment Outcome; Young Adult | 2017 |
Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol fo
Topics: Alloys; Amputation, Surgical; Angiography, Digital Subtraction; Angioplasty, Balloon; Ankle Brachial Index; Arterial Occlusive Diseases; Cardiovascular Agents; Clinical Protocols; Coated Materials, Biocompatible; Constriction, Pathologic; Equipment Design; Equipment Failure; Femoral Artery; Hemodynamics; Humans; Hyperplasia; Limb Salvage; Neointima; Netherlands; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Prosthesis Failure; Recurrence; Research Design; Resins, Plant; Single-Blind Method; Stents; Surveys and Questionnaires; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vascular Access Devices | 2013 |
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial.
Topics: Aged; Australia; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Europe; Female; Humans; Male; Middle Aged; Myocardial Infarction; Neointima; New Zealand; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2013 |
Safety and efficacy of low-dose paclitaxel utilizing the cobra-P drug-eluting stent system with a novel biodegradable coating in de novo coronary lesions: the PLUS-ONE first-in-man study.
Topics: Absorbable Implants; Aged; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Feasibility Studies; Female; Humans; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Time Factors; Treatment Outcome | 2014 |
Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment
Topics: Aged, 80 and over; Chi-Square Distribution; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Humans; Hyperplasia; Italy; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Design; Risk Factors; Sirolimus; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2014 |
Randomized comparison between polymer-free versus polymer-based paclitaxel-eluting stent: two-year final clinical results.
Topics: Aged; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Polymers; Prospective Studies; Risk Factors; Single-Blind Method; Treatment Outcome; Ultrasonography, Interventional; Vasculitis, Leukocytoclastic, Cutaneous | 2014 |
Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trials.
Topics: Aged; Cohort Studies; Coronary Angiography; Coronary Stenosis; Double-Blind Method; Drug-Eluting Stents; Equipment Failure; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Neointima; Paclitaxel; Prospective Studies; Tunica Intima; Ultrasonography, Interventional | 2014 |
Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Germany; Humans; Male; Metals; Middle Aged; Neointima; Paclitaxel; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Single-Blind Method; Sirolimus; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Access Devices | 2014 |
Determinants of neointimal proliferation and stent coverage after intracoronary therapy with drug-eluting devices in stable coronary artery disease: role of endothelial progenitor cells and interleukin-1 family cytokines.
Topics: Aged; Cell Count; Cell Proliferation; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Endothelial Progenitor Cells; Everolimus; Female; Humans; Interleukin-1; Male; Middle Aged; Neointima; Paclitaxel; Prognosis; Tomography, Optical Coherence | 2014 |
The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study.
Topics: Aged; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Disease Progression; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Neointima; Paclitaxel; Prosthesis Failure; Sirolimus; Tomography, Optical Coherence; Tubulin Modulators | 2015 |
Strut Coverage After Paclitaxel-Eluting Stent Implantation in the Superficial Femoral Artery.
Topics: Cardiovascular Agents; Drug-Eluting Stents; Endovascular Procedures; Femoral Artery; Humans; Neointima; Paclitaxel; Peripheral Arterial Disease; Prospective Studies; Prosthesis Design; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Wound Healing | 2016 |
Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial.
Topics: Aged; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Risk Factors; Single-Blind Method; Sirolimus; Stainless Steel; Surface Properties; Time Factors; Treatment Outcome | 2016 |
12-month intravascular ultrasound observations from BiOSS® first-in-man studies.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Neointima; Non-ST Elevated Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Registries; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2016 |
Comparative angioscopic evaluation of neointimal coverage and thrombus between TAXUS-Express and TAXUS-Liberté stents: is the stent platform type associated with the vascular response?
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Angioscopy; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Neointima; Paclitaxel | 2010 |
Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
Topics: Acute Coronary Syndrome; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Restenosis; Diagnosis, Differential; Disease Progression; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Paclitaxel; Prognosis; Prospective Studies; Prosthesis Failure; Time Factors; Tomography, Optical Coherence; Tunica Intima | 2011 |
STELLIUM 1: First-in-man follow-up evaluation of bioabsorbable polymer-coated paclitaxel-eluting stent.
Topics: Aged; Angina Pectoris; Coated Materials, Biocompatible; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Inflammation; Male; Middle Aged; Neointima; Paclitaxel; Polymers; Postoperative Complications; Thrombosis; Treatment Outcome | 2010 |
Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial In
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Prospective Studies; Tomography, Optical Coherence; Tubulin Modulators | 2011 |
Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Neointima; Paclitaxel; Prospective Studies; Single-Blind Method; Sirolimus; Ultrasonography, Interventional | 2011 |
Paclitaxel-eluting stents reduce neointimal hyperplasia compared to bare metal stents in saphenous vein grafts: intravascular ultrasonography analysis of the SOS (Stenting of Saphenous Vein Grafts) trial.
Topics: Aged; Antineoplastic Agents, Phytogenic; Drug-Eluting Stents; Humans; Hyperplasia; Male; Middle Aged; Neointima; Paclitaxel; Saphenous Vein; Ultrasonography, Interventional | 2011 |
Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study.
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Endothelial Cells; Female; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Stents; Time Factors; Titanium; Tomography, Optical Coherence; Treatment Outcome | 2012 |
Long-term luminal change after drug-eluting stent implantation: serial angiographic follow-up study of the ZEST randomized trial.
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Linear Models; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Republic of Korea; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome | 2013 |
INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Catheters; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Endothelial Cells; Equipment Design; Humans; Hyperplasia; Italy; Metals; Neointima; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Research Design; Stem Cells; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2012 |
Impact of stent platform of paclitaxel-eluting stents: assessment of neointimal distribution on optical coherence tomography.
Topics: Aged; Aged, 80 and over; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Paclitaxel; Prosthesis Design; Tomography, Optical Coherence; Tubulin Modulators | 2012 |
Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Equipment Failure; Follow-Up Studies; Foreign-Body Migration; Humans; Incidence; Middle Aged; Neointima; Paclitaxel; Sirolimus; Stents; Treatment Outcome; Ultrasonography, Interventional | 2012 |
Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
Topics: Angioplasty, Balloon, Coronary; Bayes Theorem; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Neointima; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Wound Healing | 2012 |
Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial.
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Hyperplasia; Japan; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Registries; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional; United States | 2012 |
83 other study(ies) available for paclitaxel and Neointima
| Article | Year |
|---|---|
One single drug-coated balloon for all shapes/diameters? Neointimal proliferation inhibition in porcine peripheral arteries.
Topics: Angioplasty, Balloon; Animals; Cell Proliferation; Coated Materials, Biocompatible; Constriction, Pathologic; Coronary Vessels; Neointima; Paclitaxel; Stents; Swine | 2023 |
Poor Below Knee Runoff Impacts Femoropopliteal Stent Failure and Fluoropolymer Antithrombotic Effect in Healthy Swine Model.
Topics: Animals; Constriction, Pathologic; Drug-Eluting Stents; Femoral Artery; Fibrinolytic Agents; Fluorocarbon Polymers; Neointima; Paclitaxel; Polymers; Stents; Swine; Thrombosis; Treatment Outcome | 2023 |
Assessment of Vascular Patency and Inflammation with Intravascular Optical Coherence Tomography in Patients with Superficial Femoral Artery Disease Treated with Zilver PTX Stents.
Topics: Aged; Aged, 80 and over; Alloys; Angioplasty, Balloon; Cardiovascular Agents; Drug-Eluting Stents; Female; Femoral Artery; Humans; Inflammation; Male; Middle Aged; Neointima; Paclitaxel; Peripheral Arterial Disease; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Risk Factors; Self Expandable Metallic Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Patency; Vascular Remodeling | 2020 |
The Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System.
Topics: Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Consumer Product Safety; Drug-Eluting Stents; Endovascular Procedures; Graft Occlusion, Vascular; Humans; Long Term Adverse Effects; Meta-Analysis as Topic; Neointima; Paclitaxel; Peripheral Arterial Disease; Product Surveillance, Postmarketing | 2020 |
Novel, vessel anatomy adjusting drug-coated balloon-Preclinical evaluation in peripheral porcine arteries.
Topics: Angiography; Angioplasty, Balloon; Animals; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Equipment Design; Iliac Artery; Neointima; Paclitaxel; Sus scrofa; Time Factors; Tomography, Optical Coherence; Vascular Access Devices | 2020 |
Adventitial injection delivery of nano-encapsulated sirolimus (Nanolimus) to injury-induced porcine femoral vessels to reduce luminal restenosis.
Topics: Animals; Constriction, Pathologic; Female; Femoral Artery; Lower Extremity; Neointima; Paclitaxel; Sirolimus; Swine | 2020 |
A Novel Epigenetic Drug-Eluting Balloon Angioplasty Device: Evaluation in a Large Animal Model of Neointimal Hyperplasia.
Topics: Angioplasty, Balloon; Animals; Carotid Artery Diseases; Carotid Artery, Common; Cell Proliferation; Cells, Cultured; Coated Materials, Biocompatible; Disease Models, Animal; Epigenesis, Genetic; Equipment Design; Female; Histone Deacetylase Inhibitors; Human Umbilical Vein Endothelial Cells; Humans; Inflammation Mediators; Neointima; Paclitaxel; Sheep, Domestic; Time Factors; Vascular Access Devices | 2019 |
Comparative Analysis of the Paclitaxel-Eluting Peripheral Igaki-Tamai Stent and the Drug-Free Igaki-Tamai Stent Using Optical Coherence Tomography and Histological Analysis in a Porcine Iliac Artery Model.
Topics: Angioplasty, Balloon; Animals; Cardiovascular Agents; Drug-Eluting Stents; Female; Iliac Artery; Male; Models, Animal; Neointima; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Stents; Sus scrofa; Tomography, Optical Coherence | 2020 |
Influence of Self-Expanding Paclitaxel-Eluting Stent Sizing on Neointimal Hyperplasia in Superficial Femoral Artery Lesions.
Topics: Aged; Drug-Eluting Stents; Endovascular Procedures; Female; Femoral Artery; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Neointima; Paclitaxel; Peripheral Arterial Disease; Prospective Studies; Prosthesis Design; Self Expandable Metallic Stents; Tomography, Optical Coherence; Treatment Outcome | 2020 |
Angioscopic Assessments at 3 Months After Fluoropolymer-Based Paclitaxel-Eluting Stent Implantation for Femoropopliteal Endovascular Intervention.
Topics: Angioscopy; Coronary Vessels; Drug-Eluting Stents; Femoral Artery; Humans; Neointima; Paclitaxel; Popliteal Artery; Treatment Outcome | 2020 |
Vascular Response of a Polymer-Free Paclitaxel-Coated Stent (Zilver PTX) versus a Polymer-Coated Paclitaxel-Eluting Stent (Eluvia) in Healthy Swine Femoropopliteal Arteries.
Topics: Animals; Cardiovascular Agents; Drug-Eluting Stents; Endovascular Procedures; Femoral Artery; Neointima; Paclitaxel; Polymers; Prosthesis Design; Swine; Swine, Miniature; Time Factors; Vascular Remodeling; Wound Healing | 2021 |
Design, Development, In Vitro and Preliminary In Vivo Evaluation of a Novel Photo-Angioplasty Device: Lumi-Solve.
Topics: Angioplasty; Animals; Carotid Artery, Common; Hyperplasia; Neointima; Paclitaxel; Sheep | 2021 |
Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats.
Topics: Allografts; Animals; Antineoplastic Agents, Phytogenic; Aorta; Apoptosis Regulatory Proteins; Graft Rejection; Interferon-gamma; Interleukin-1beta; Nanoparticle Drug Delivery System; Neointima; Paclitaxel; Rats; Treatment Outcome; Tumor Necrosis Factor-alpha; Vascular Grafting | 2021 |
Impact of Fluoropolymer-Based Paclitaxel Delivery on Neointimal Proliferation and Vascular Healing: A Comparative Peripheral Drug-Eluting Stent Study in the Familial Hypercholesterolemic Swine Model of Femoral Restenosis.
Topics: Angiography; Animals; Cardiovascular Agents; Cell Proliferation; Constriction, Pathologic; Disease Models, Animal; Drug-Eluting Stents; Endovascular Procedures; Femoral Artery; Hyperlipoproteinemia Type II; Methacrylates; Neointima; Paclitaxel; Peripheral Arterial Disease; Polymers; Polyvinyls; Prosthesis Design; Recurrence; Sus scrofa; Time Factors; Tomography, Optical Coherence; Vascular Patency; Wound Healing | 2017 |
Effect of drug-coated balloon on stent restenosis, neointimal proliferation, and coronary dissection: an optical coherence tomography analysis.
Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Tomography, Optical Coherence; Tubulin Modulators | 2018 |
Biologic Drug Effect and Particulate Embolization of Drug-Eluting Stents versus Drug-Coated Balloons in Healthy Swine Femoropopliteal Arteries.
Topics: Angioplasty, Balloon; Animals; Cardiovascular Agents; Coated Materials, Biocompatible; Drug-Eluting Stents; Femoral Artery; Fibrin; Models, Animal; Muscle, Skeletal; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Paclitaxel; Popliteal Artery; Proteoglycans; Sus scrofa; Time Factors; Vascular Access Devices | 2018 |
Overwhelming Suppression of Neointimal Coverage on High-Resolution Coronary Angioscopy After Paclitaxel-Coated Balloon Angioplasty for In-Stent Restenosis of Cobalt-Chrome Everolimus-Eluting Stent.
Topics: Angioplasty, Balloon, Coronary; Angioscopy; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Humans; Male; Middle Aged; Neointima; Paclitaxel | 2018 |
Drug Distribution and Basic Pharmacology of Paclitaxel/Resveratrol-Coated Balloon Catheters.
Topics: Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Animals; Coated Materials, Biocompatible; In Vitro Techniques; Neointima; Paclitaxel; Resveratrol; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Stilbenes; Swine | 2018 |
A serial 3- and 9-year optical coherence tomography assessment of vascular healing response to sirolimus- and paclitaxel-eluting stents.
Topics: Aged; Cardiovascular Agents; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Longitudinal Studies; Male; Middle Aged; Neointima; Observer Variation; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prosthesis Design; Reproducibility of Results; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Wound Healing | 2019 |
Vascular response to paclitaxel-eluting nitinol self-expanding stent in superficial femoral artery lesions: post-implantation angioscopic findings from the SHIMEJI trial (Suppression of vascular wall Healing after IMplantation of drug Eluting peripheral s
Topics: Aged; Aged, 80 and over; Alloys; Angioscopy; Cardiovascular Agents; Cell Proliferation; Drug-Eluting Stents; Endovascular Procedures; Female; Femoral Artery; Humans; Japan; Male; Middle Aged; Neointima; Paclitaxel; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Registries; Risk Factors; Self Expandable Metallic Stents; Time Factors; Treatment Outcome; Wound Healing | 2019 |
Clinical significance of low signal intensity area surrounding stent struts identified by optical coherence tomography.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Humans; Hyperplasia; Immunosuppressive Agents; Japan; Male; Middle Aged; Neointima; Outcome Assessment, Health Care; Paclitaxel; Postoperative Complications; Prospective Studies; Sirolimus; Stents; Tomography, Optical Coherence; Tubulin Modulators | 2013 |
The effect of short-term intra-arterial delivery of paclitaxel on neointimal hyperplasia and the local thrombotic environment after angioplasty.
Topics: Angioplasty, Balloon; Animals; Biopsy, Needle; Carotid Artery Injuries; Carotid Artery, Common; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Hyperplasia; Immunohistochemistry; Infusions, Intra-Arterial; Male; Neointima; Paclitaxel; Random Allocation; Rats; Rats, Wistar; Risk Assessment; Thromboplastin; Thrombosis; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2013 |
Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.
Topics: Angioplasty, Balloon, Coronary; Animals; Apoptosis; Cardiac Catheters; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Equipment Design; Immunohistochemistry; In Situ Nick-End Labeling; Metals; Muscle, Smooth, Vascular; Neointima; Paclitaxel; Prosthesis Design; Stents; Swine; Swine, Miniature; Time Factors | 2013 |
Bioresorbable drug-eluting magnesium-alloy scaffold: design and feasibility in a porcine coronary model.
Topics: Absorbable Implants; Alloys; Animals; Cardiovascular Agents; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Feasibility Studies; Female; Fibrosis; Kinetics; Magnesium; Male; Materials Testing; Models, Animal; Molecular Weight; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Polyglactin 910; Prosthesis Design; Swine; Swine, Miniature | 2013 |
Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine.
Topics: Angioplasty, Balloon; Animals; Cardiovascular Agents; Cell Proliferation; Chromatography, High Pressure Liquid; Coated Materials, Biocompatible; Crystallization; Drug-Eluting Stents; Female; Femoral Artery; Hyperplasia; Iliac Artery; Male; Materials Testing; Models, Animal; Neointima; Paclitaxel; Prosthesis Design; Radiography; Sus scrofa; Wound Healing | 2014 |
Tissue coverage of paclitaxel and sirolimus eluting stents in long term follow-up: optical coherence tomography study.
Topics: Aged; Cardiovascular Agents; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Registries; Retrospective Studies; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2013 |
The relationship between re-endothelialization and endothelial function after DES implantation: comparison between paclitaxcel eluting stent and zotarolims eluting stent.
Topics: Acetylcholine; Aged; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Endothelial Cells; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Re-Epithelialization; Retrospective Studies; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vasoconstriction; Vasoconstrictor Agents | 2014 |
Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury.
Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Constriction, Pathologic; Coronary Artery Disease; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Iohexol; Neointima; Paclitaxel; Polymers; Swine | 2013 |
Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Constriction, Pathologic; Contrast Media; Disease Models, Animal; Equipment Design; Femoral Artery; Fibrosis; Hyperlipoproteinemia Type II; Iliac Artery; Iohexol; Neointima; Paclitaxel; Radiography; Sus scrofa; Tissue Distribution; Vascular Access Devices; Wound Healing | 2013 |
[SICI-GISE position paper on drug-coated balloon use in the coronary district].
Topics: Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Coronary Restenosis; Cost-Benefit Analysis; Drug-Eluting Stents; Equipment Design; Evidence-Based Medicine; Humans; Multicenter Studies as Topic; Myocardial Infarction; Neointima; Paclitaxel; Platelet Aggregation Inhibitors; Registries | 2013 |
Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans.
Topics: Aged; Aged, 80 and over; Autopsy; Biocompatible Materials; Chromium Alloys; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Neointima; Paclitaxel; Prevalence; Registries; Retrospective Studies; Sirolimus | 2014 |
PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design.
Topics: Animals; Cell Proliferation; Cells, Cultured; Chemotaxis; Drug-Eluting Stents; Endothelium, Vascular; GTP Phosphohydrolases; Hydrazones; Immunosuppressive Agents; Leukocytes, Mononuclear; Male; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Neointima; NF-kappaB-Inducing Kinase; Nitric Oxide; Paclitaxel; Phosphoinositide-3 Kinase Inhibitors; Plasminogen Activator Inhibitor 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; RNA Interference; RNA, Small Interfering; Sirolimus; Sulfonamides; Thrombosis; Tumor Necrosis Factor-alpha | 2014 |
Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms.
Topics: Absorbable Implants; Animals; Coated Materials, Biocompatible; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Endothelium, Vascular; Everolimus; Hyperplasia; Inflammation; Models, Animal; Neointima; Paclitaxel; Polymers; Sirolimus; Stents; Swine | 2014 |
Difference of neointimal growth patterns in bifurcation lesions among four kinds of drug-eluting stents: an optical coherence tomographic study.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Stenosis; Cross-Sectional Studies; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Paclitaxel; Prosthesis Failure; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional | 2014 |
Optical coherence tomography imaging of intrastent neointimal bridge caused by semicircumferencial dissection after drug eluting balloon dilatation of instent restenosis of sapheneous venous graft.
Topics: Coronary Artery Bypass; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Middle Aged; Neointima; Paclitaxel; Saphenous Vein; Tomography, Optical Coherence; Ultrasonography, Interventional; Video Recording | 2014 |
Paclitaxel coating on the terminal portion of hemodialysis grafts effectively suppresses neointimal hyperplasia in a porcine model.
Topics: Animals; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Carotid Artery, Common; Coated Materials, Biocompatible; Constriction, Pathologic; Disease Models, Animal; Female; Graft Occlusion, Vascular; Hyperplasia; Jugular Veins; Neointima; Paclitaxel; Polytetrafluoroethylene; Prosthesis Design; Renal Dialysis; Swine; Time Factors | 2015 |
Different serial changes in the neointimal condition of sirolimus-eluting stents and paclitaxel-eluting stents: an optical coherence tomographic study.
Topics: Acute Coronary Syndrome; Aged; Antineoplastic Agents; Cohort Studies; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Progression; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Sirolimus; Tomography, Optical Coherence | 2014 |
Illuminating and alarming insights into vascular healing.
Topics: Cardiovascular Agents; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Neointima; Paclitaxel; Sirolimus | 2014 |
Analysis by optical coherence tomography of long-term arterial healing after implantation of different types of stents.
Topics: Aged; Cardiovascular Agents; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Sirolimus; Tomography, Optical Coherence | 2014 |
Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studies.
Topics: Aged; Angina, Stable; Angina, Unstable; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Randomized Controlled Trials as Topic; Stents; Tubulin Modulators; Ultrasonography, Interventional | 2014 |
Coronary angioscopy and optical coherence tomography for confirmation of drug-coated neointimal plaque after paclitaxel-coated balloon angioplasty for in-stent restenosis.
Topics: Aged; Angioplasty, Balloon, Coronary; Angioscopy; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Coronary Vessels; Humans; Male; Neointima; Paclitaxel; Prosthesis Failure; Stents; Tomography, Optical Coherence | 2014 |
Coronary slow-flow phenomenon after paclitaxel-coated balloon angioplasty for neointimal plaque confirmed by optical coherence tomography.
Topics: Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Angiography; Coronary Vessels; Female; Humans; Middle Aged; Neointima; No-Reflow Phenomenon; Paclitaxel; Tomography, Optical Coherence | 2014 |
Neointimal hemorrhage after drug-eluting stent implantation: possible role for development of neoatherosclerosis.
Topics: Autopsy; Cardiovascular Agents; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Fatal Outcome; Hemorrhage; Humans; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Prosthesis Design; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional | 2014 |
Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis.
Topics: Aged; Angioplasty, Balloon; Blood Flow Velocity; Cardiovascular Agents; Carotid Stenosis; Drug-Eluting Stents; Endovascular Procedures; Female; Humans; Hyperplasia; Male; Middle Aged; Neointima; Paclitaxel; Prosthesis Design; Recurrence; Regional Blood Flow; Retreatment; Risk Factors; Stents; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler; Vascular Patency | 2014 |
Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Female; Humans; Hyperplasia; Male; Middle Aged; Neointima; Paclitaxel; Retrospective Studies; Time Factors; Treatment Outcome; Vascular Remodeling | 2015 |
Colchicine reduces restenosis after balloon angioplasty treatment for in-stent restenosis.
Topics: Angioplasty, Balloon, Coronary; Animals; Colchicine; Combined Modality Therapy; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Muscle, Smooth, Vascular; Neointima; Paclitaxel; Proliferating Cell Nuclear Antigen; Random Allocation; Swine; Swine, Miniature; Treatment Outcome | 2015 |
Targeted inhibitory effect of Lenti-SM22alpha-p27-EGFP recombinant lentiviral vectors on proliferation of vascular smooth muscle cells without compromising re-endothelialization in a rat carotid artery balloon injury model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Balloon Occlusion; Carotid Arteries; Cell Proliferation; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Endothelium, Vascular; G1 Phase Cell Cycle Checkpoints; Green Fluorescent Proteins; Lentivirus; Male; Microfilament Proteins; Muscle Proteins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Paclitaxel; Rats, Wistar; Vascular Remodeling; Wound Healing | 2015 |
Vascular response after Zilver PTX stent implantation for superficial femoral artery lesions: serial optical coherence tomography findings at 6 and 12 months.
Topics: Aged; Aged, 80 and over; Alloys; Cardiovascular Agents; Drug-Eluting Stents; Female; Femoral Artery; Follow-Up Studies; Humans; Male; Neointima; Paclitaxel; Peripheral Arterial Disease; Predictive Value of Tests; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, Optical Coherence; Treatment Outcome | 2015 |
The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term.
Topics: Aged; Angioscopy; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Humans; Immunohistochemistry; Male; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Retreatment; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Wound Healing | 2016 |
Impact of Paclitaxel Dose on Tissue Pharmacokinetics and Vascular Healing: A Comparative Drug-Coated Balloon Study in the Familial Hypercholesterolemic Swine Model of Superficial Femoral In-Stent Restenosis.
Topics: Animals; Cardiovascular Agents; Coated Materials, Biocompatible; Constriction, Pathologic; Disease Models, Animal; Endovascular Procedures; Femoral Artery; Fibrin; Hyperlipoproteinemia Type II; Metals; Neointima; Paclitaxel; Peripheral Arterial Disease; Radiography; Stents; Swine; Tissue Distribution; Vascular Access Devices; Wound Healing | 2015 |
Cell Cycle Regulation of Smooth Muscle Cells--Searching for Inhibitors of Neointima Formation: Is Combretastatin A4 an Alternative to Sirolimus and Paclitaxel?
Topics: Cell Cycle; Cell Proliferation; Cells, Cultured; Humans; Myocytes, Smooth Muscle; Neointima; Paclitaxel; Sirolimus; Stilbenes; Treatment Outcome; Tubulin Modulators | 2015 |
Mechanisms and Patterns of Intravascular Ultrasound In-Stent Restenosis Among Bare Metal Stents and First- and Second-Generation Drug-Eluting Stents.
Topics: Aged; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Metals; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Retrospective Studies; Risk Factors; Sirolimus; Stents; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2015 |
Optical coherence tomography study of chronic-phase vessel healing after implantation of bare metal and paclitaxel-eluting self-expanding nitinol stents in the superficial femoral artery.
Topics: Aged; Alloys; Female; Femoral Artery; Humans; Macrophages; Male; Neointima; Paclitaxel; Retrospective Studies; Stents; Tomography, Optical Coherence; Wound Healing | 2016 |
Biological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model.
Topics: Animals; Cardiac Catheterization; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Equipment and Supplies; Fibrin; Metals; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Stents; Swine; Tissue Distribution; Tomography, Optical Coherence; Wound Healing | 2016 |
Coating of intravascular balloon with paclitaxel prevents constrictive remodeling of the dilated porcine femoral artery due to inhibition of intimal and media fibrosis.
Topics: Angiography; Angioplasty, Balloon; Animals; Coated Materials, Biocompatible; Equipment Design; Femoral Artery; Fibrosis; Hyperplasia; Iliac Artery; Materials Testing; Models, Animal; Neointima; Paclitaxel; Sus scrofa; Swine; Tomography, Optical Coherence; Tunica Intima; Tunica Media; Vasoconstriction; Vasodilation | 2016 |
Rescuing Impaired Re-endothelialization of Drug-Eluting Stents Using the Hepatocyte Growth Factor.
Topics: Angioplasty, Balloon; Animals; Apoptosis; Cardiovascular Agents; Carotid Arteries; Carotid Artery Diseases; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Eluting Stents; Endothelial Progenitor Cells; Hepatocyte Growth Factor; Hypercholesterolemia; Injections, Subcutaneous; Male; Neointima; Paclitaxel; Rabbits; Re-Epithelialization; Time Factors | 2016 |
Fluorocopolymer-coated nitinol self-expanding paclitaxel-eluting stent: pharmacokinetics and vascular biology responses in a porcine iliofemoral model.
Topics: Alloys; Animals; Antineoplastic Agents, Phytogenic; Cell Movement; Coronary Vessels; Drug-Eluting Stents; Femoral Artery; Humans; Models, Animal; Myocytes, Smooth Muscle; Neointima; Paclitaxel; Polymers; Swine | 2016 |
Differential angioscopic findings of neointimal coverage among first-, second-, and next generation drug-eluting stents.
Topics: Angioscopy; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Neointima; Paclitaxel; Prosthesis Design; Sirolimus | 2016 |
Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel-Coated Balloons in Healthy Swine.
Topics: Angioplasty, Balloon; Animals; Arterioles; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Vessels; Embolism; Equipment Design; Femoral Artery; Fibrosis; Models, Animal; Muscle, Skeletal; Necrosis; Neointima; Paclitaxel; Sus scrofa; Time Factors; Vascular Access Devices | 2016 |
Biological effect on restenosis and vascular healing of encapsulated paclitaxel nanocrystals delivered via coated balloon technology in the familial hypercholesterolaemic swine model of in-stent restenosis.
Topics: Angiography; Angioplasty, Balloon, Coronary; Animals; Antineoplastic Agents; Disease Models, Animal; Femoral Artery; Graft Occlusion, Vascular; Hyperlipoproteinemia Type II; Iliac Artery; Metals; Nanoparticles; Neointima; Paclitaxel; Peripheral Vascular Diseases; Stents; Sus scrofa; Swine; Tomography, Optical Coherence; Wound Healing | 2016 |
A novel constrained, paclitaxel-coated angioplasty balloon catheter.
Topics: Alloys; Angioplasty, Balloon, Coronary; Animals; Antineoplastic Agents, Phytogenic; Male; Neointima; Paclitaxel; Swine | 2017 |
Comparing the vascular response in implantation of self-expanding, bare metal nitinol stents or paclitaxel-eluting nitinol stents in superficial femoral artery lesions: a serial optical frequency domain imaging study.
Topics: Adult; Aged; Aged, 80 and over; Alloys; Drug-Eluting Stents; Female; Femoral Artery; Humans; Male; Middle Aged; Neointima; Optical Imaging; Paclitaxel; Ultrasonography, Interventional | 2016 |
Evaluation of the peri-strut low intensity area following sirolimus- and paclitaxel-eluting stents implantation: insights from an optical coherence tomography study in humans.
Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Paclitaxel; Radiography; Retrospective Studies; Sirolimus; Tomography, Optical Coherence; Treatment Outcome | 2012 |
Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis.
Topics: Angioplasty, Balloon; Animals; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Endothelium, Vascular; Fibrin; Humans; Neointima; Paclitaxel; Swine; Wound Healing | 2011 |
Serial angioscopic evaluation of neointimal coverage and incidence of thrombus formation after Paclitaxel-eluting stent implantation: comparison between 6- and 18-month follow-up.
Topics: Aged; Angioscopy; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Health Status Indicators; Humans; Incidence; Male; Neointima; Paclitaxel; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Assessment; Statistics, Nonparametric; Ticlopidine; Time Factors; Treatment Outcome | 2011 |
Comparison of bare metal stent and paclitaxel-eluting stent using a novel rat aorta stent model.
Topics: Angioplasty; Animals; Aorta, Thoracic; Coronary Artery Disease; Drug-Eluting Stents; Histocytochemistry; Male; Microscopy, Electron, Scanning; Models, Animal; Neointima; Paclitaxel; Rats; Rats, Sprague-Dawley | 2011 |
Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Hyperplasia; Lipid Metabolism; Male; Middle Aged; Neointima; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2012 |
Risk of in-stent thrombus formation at one year after drug-eluting stent implantation.
Topics: Aged; Angioscopy; Color; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Neointima; Paclitaxel; Regression Analysis; Risk; Risk Factors; Thrombosis | 2011 |
Paclitaxel-iopromide coated balloon followed by "bail-out" bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation.
Topics: Angioplasty, Balloon; Animals; Blood Circulation; Cell Proliferation; Dose-Response Relationship, Drug; Drug Delivery Systems; Femoral Artery; Iohexol; Metals; Models, Animal; Neointima; Paclitaxel; Pilot Projects; Radiography; Regional Blood Flow; Stents; Swine | 2011 |
Vascular responses to drug-eluting and bare metal stents in diabetic/hypercholesterolemic and nonatherosclerotic porcine coronary arteries.
Topics: Animals; Blood Vessel Prosthesis Implantation; Cell Movement; Coronary Artery Disease; Coronary Vessels; Diabetes Complications; Disease Progression; Drug-Eluting Stents; Humans; Hypercholesterolemia; Inflammation; Models, Animal; Neointima; Paclitaxel; Platelet Aggregation; Platelet Aggregation Inhibitors; Swine; T-Lymphocytes | 2011 |
Suppression of neointimal hyperplasia by sirolimus-eluting expanded polytetrafluoroethylene (ePTFE) haemodialysis grafts in comparison with paclitaxel-coated grafts.
Topics: Animals; Arteriovenous Shunt, Surgical; Carotid Arteries; Cell Proliferation; Constriction, Pathologic; Female; Graft Occlusion, Vascular; Hyperplasia; Jugular Veins; Models, Animal; Neointima; Paclitaxel; Polytetrafluoroethylene; Renal Dialysis; Sirolimus; Swine; Vascular Grafting | 2012 |
In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles.
Topics: Animals; Collagen Type IV; Coronary Restenosis; Immunohistochemistry; Male; Mice; Nanoparticles; Neointima; Paclitaxel; Peptides; Rats; Rats, Sprague-Dawley | 2011 |
Inhibition of neointimal proliferation after bare metal stent implantation with low-pressure drug delivery using a paclitaxel-coated balloon in porcine coronary arteries.
Topics: Angioplasty, Balloon, Coronary; Animals; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Male; Neointima; Paclitaxel; Pressure; Stents; Swine | 2012 |
Preclinical evaluation of a novel drug-eluting balloon in an animal model of in-stent stenosis.
Topics: Angioplasty, Balloon, Coronary; Animals; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Drug Delivery Systems; Female; Humans; Neointima; Paclitaxel; Stents; Swine; Swine, Miniature; Wound Healing | 2013 |
Long-term effects on vascular healing of bare metal stents delivered via paclitaxel-coated balloons in the porcine model of restenosis.
Topics: Angioplasty, Balloon, Coronary; Animals; Cardiac Catheters; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Endothelial Cells; Equipment Design; Metals; Neointima; Paclitaxel; Prosthesis Design; Stents; Swine; Swine, Miniature; Time Factors; von Willebrand Factor | 2012 |
Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel?
Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Catheters; Chromatography, High Pressure Liquid; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Half-Life; Mass Spectrometry; Myocardium; Neointima; Paclitaxel; Spectrophotometry, Ultraviolet; Stents; Sus scrofa; Swine; Swine, Miniature; Tissue Distribution | 2012 |
Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries.
Topics: Animals; Apoptosis; Cardiovascular Agents; Cells, Cultured; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Eluting Stents; Endothelial Cells; Everolimus; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Necrosis; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Sirolimus; Swine; Time Factors; Wound Healing | 2012 |
Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification.
Topics: Animals; Aspirin; Atherosclerosis; Drug-Eluting Stents; Endothelial Cells; Endothelium, Vascular; Fibrinolytic Agents; Male; Mice; Mice, Inbred Strains; Neointima; Paclitaxel; Stents; Tubulin Modulators | 2013 |
Differences in optical coherence tomographic findings and clinical outcomes between excimer laser and cutting balloon angioplasty for focal in-stent restenosis lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Lasers, Excimer; Male; Middle Aged; Neointima; Paclitaxel; Retrospective Studies; Sirolimus; Tomography, Optical Coherence; Treatment Outcome | 2012 |
Neointimal tissue healing patterns after paclitaxel-eluting balloon treatment of in-stent restenosis: optical coherence tomography and intravascular ultrasound insights.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Follow-Up Studies; Humans; Male; Neointima; Paclitaxel; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional; Wound Healing | 2012 |
Serial optical coherence tomography-based observation of strut coverage on drug-eluting stent crossing side-branch vessels.
Topics: Aged; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Sirolimus; Time Factors; Tomography, Optical Coherence | 2012 |
Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
Topics: Aged; Cardiovascular Agents; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Registries; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2012 |
Qualitative and quantitative assessment of stent restenosis by optical coherence tomography: comparison between drug-eluting and bare-metal stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Incidence; Male; Metals; Middle Aged; Neointima; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Tomography, Optical Coherence; Treatment Outcome | 2013 |